Large-Scale Multi-omic Analysis of COVID-19 Severity

Area of Science:

• Multi-omics analysis
• Systems biology
• Infectious disease research

Background:

• COVID-19 presents with diverse clinical manifestations and outcomes.
• Understanding the molecular underpinnings of COVID-19 severity is crucial for effective treatment.

Purpose of the Study:

• To perform a comprehensive multi-omics analysis of blood samples from COVID-19 patients.
• To correlate molecular features with disease severity and clinical outcomes.
• To identify novel biomarkers and therapeutic targets for COVID-19.

Main Methods:

• RNA sequencing (RNA-seq) and high-resolution mass spectrometry were employed on 128 blood samples.
• Data integration into a curated relational database enabled systems analysis and cross-ome correlations.
• Machine learning approaches were utilized for predicting COVID-19 severity.

Main Results:

• 219 molecular features significantly associated with COVID-19 status and severity were identified.
• Key pathways implicated include complement activation, dysregulated lipid transport, and neutrophil activation.
• Covarying molecular sets provided pathophysiological insights and suggested therapeutic avenues.
• Dysregulation in platelet function, coagulation, acute phase response, and endotheliopathy characterized the COVID-19 phenotype.

Conclusions:

• The study presents a comprehensive molecular compendium of COVID-19.
• Identified molecular signatures offer potential for improved diagnostics and therapeutics.
• A web-based tool (covid-omics.app) facilitates interactive exploration of the data.